VS101 subconjunctival latanoprost insert
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VS101 subconjunctival latanoprost insert, covering 2018-03-14 to 2018-03-14. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1/2 Multicenter, Randomized, Study to Evaluate the Safety and Efficacy of VS101 Subconjunctival Latanoprost Insert in Subjects With Open-Angle Glaucoma or Ocular Hypertension [Phase 1, Phase 2]